Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Analysis of the T-cell repertoire and transcriptome identifies mechanisms of regulatory T-cell suppression of GVHD

Juliane K. Lohmeyer, Toshihito Hirai, Mustafa Turkoz, Stephane Buhler, Teresa Lopes Ramos, Natalie Köhler, Jeanette Baker, Astrid Melotti, Ingrid Wagner, Amandine Pradier, Sisi Wang, Xuhuai Ji, Simone Becattini, Jean Villard, Doron Merkler, Yves Chalandon, Robert S. Negrin, Federico Simonetta

Blood (2023) 141 (14): 1755–1767.

https://doi.org/10.1182/blood.2022017982

Published: 2023

Includes: Supplemental data

Journal Articles

RNA and TCR Sequencing Shed Light on Mechanisms of Treg Suppression in a Murine Model of Acute GvHD

Juliane K. Lohmeyer, MD, Toshihito Hirai, MD PhD, Mustafa Turkoz, PhD, Natalie Koehler, PhD, Jeanette Baker, Stephane Buhler, PhD, Jean Villard, MD PhD, Xuhuai Ji, MD PhD, Federico Simonetta, MD PhD, Robert S. Negrin, MD

Blood (2020) 136 (Supplement 1): 30.

https://doi.org/10.1182/blood-2020-137220

Published: 2020

Journal Articles

Quantification of Chimerism and Graft Immune Cell Composition with Alloseq HCT, a Highly Sensitive and Precise Next-Generation Sequencing Assay, in Patients Post-Hematopoietic Stem Cell Transplantation

Zuleika Calderin-Sollet, PhD, Paul Kyle, Silvia Casas, BS, Marica Grskovic, PhD, Thierry Viard, PhD, Jean Villard, MD PhD

Blood (2020) 136 (Supplement 1): 35.

https://doi.org/10.1182/blood-2020-140838

Published: 2020

Journal Articles

HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation

Effie W. Petersdorf, Philip Stevenson, Mats Bengtsson, Dianne De Santis, Valerie Dubois, Ted Gooley, Mary Horowitz, Katharine Hsu, J. Alejandro Madrigal, Mari Malkki, Caroline McKallor, Yasuo Morishima, Machteld Oudshoorn, Stephen R. Spellman, Jean Villard, Mary Carrington

Blood (2020) 136 (3): 362–369.

https://doi.org/10.1182/blood.2020005743

Published: 2020

Includes: Supplemental data

Journal Articles

Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications

Yves Chalandon, Sylvie Degermann, Jean Villard, Lionel Arlettaz, Laurent Kaiser, Solange Vischer, Steffen Walter, Mirjam H. M. Heemskerk, Rene A. W. van Lier, Claudine Helg, Bernard Chapuis, Eddy Roosnek

Blood (2006) 107 (1): 389–396.

https://doi.org/10.1182/blood-2005-07-2746

Published: 2006

Journal Articles

Fludarabine Treatment Is Associated with Depletion of Host CD4+CD25 high , FOXP3+, CTLA-4+ Cells and Increased Incidences of Full Donor Chimerism and GVHD in Non-Myeloablative Haploidentical Hematopoietic Cell Transplant Recipients.

Juanita M. Shaffer, Jean Villard, Terry Means, David Dombkowski, Bimalangshu Dey, Steven McAffee, Karen Ballen, Karen Power, Susan Saidman, Fredric Preffer, Thomas R. Spitzer, Megan Sykes

Blood (2005) 106 (11): 2898.

https://doi.org/10.1182/blood.V106.11.2898.2898

Published: 2005

Journal Articles

Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors

Valérie Bigouret, Till Hoffmann, Lionel Arlettaz, Jean Villard, Marco Colonna, André Ticheli, Alois Gratwohl, Kaveh Samii, Bernard Chapuis, Nathalie Rufer, Eddy Roosnek

Blood (2003) 101 (8): 3198–3204.

https://doi.org/10.1182/blood-2002-08-2408

Published: 2003

NARROW

Analysis of the T-cell repertoire and transcriptome identifies mechanisms of regulatory T-cell suppression of GVHD

RNA and TCR Sequencing Shed Light on Mechanisms of Treg Suppression in a Murine Model of Acute GvHD

Quantification of Chimerism and Graft Immune Cell Composition with Alloseq HCT, a Highly Sensitive and Precise Next-Generation Sequencing Assay, in Patients Post-Hematopoietic Stem Cell Transplantation

HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation

Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications

Fludarabine Treatment Is Associated with Depletion of Host CD4+CD25 high , FOXP3+, CTLA-4+ Cells and Increased Incidences of Full Donor Chimerism and GVHD in Non-Myeloablative Haploidentical Hematopoietic Cell Transplant Recipients.

Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors

Email alerts

ASH Publications

American Society of Hematology

Analysis of the T-cell repertoire and transcriptome identifies mechanisms of regulatory T-cell suppression of GVHD

RNA and TCR Sequencing Shed Light on Mechanisms of Treg Suppression in a Murine Model of Acute GvHD

Quantification of Chimerism and Graft Immune Cell Composition with Alloseq HCT, a Highly Sensitive and Precise Next-Generation Sequencing Assay, in Patients Post-Hematopoietic Stem Cell Transplantation

HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation

Pretransplantation CMV-specific T cells protect recipients of T-cell-depleted grafts against CMV-related complications

Fludarabine Treatment Is Associated with Depletion of Host CD4+CD25 high , FOXP3+, CTLA-4+ Cells and Increased Incidences of Full Donor Chimerism and GVHD in Non-Myeloablative Haploidentical Hematopoietic Cell Transplant Recipients.

Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only